NCT01836289 High-dose Cyclophosphamide for Severe Refractory Crohn Disease Status WITHDRAWN Phase PHASE1/PHASE2
NCT01828190 The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers Status COMPLETED Phase NA
NCT01827631 Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01826188 Combined THC and CBD Drops for Treatment of Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01823042 The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD) Status UNKNOWN Phase NA
NCT01823029 Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia Status COMPLETED Phase NA
NCT01820247 Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission Status UNKNOWN Phase NA
NCT01817972 Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease Status UNKNOWN Phase PHASE3
NCT01813500 Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients Status COMPLETED Phase N/A
NCT01810185 Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease Status WITHDRAWN Phase PHASE2
NCT01809275 Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01802593 Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure Status TERMINATED Phase PHASE4
NCT01793376 Development of Niv Score of Capsule Endoscopy in Patients With Crohn's (CECDAIic) Status COMPLETED Phase N/A
NCT01787786 Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels Status WITHDRAWN Phase N/A
NCT01765998 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Status UNKNOWN Phase PHASE4
NCT01759264 An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR) Status COMPLETED Phase N/A
NCT01759017 PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease Status TERMINATED Phase N/A